Genes in panel
STRs in panel
Prev Next

COVID-19 research

Gene: F12

Green List (high evidence)

F12 (coagulation factor XII)
EnsemblGeneIds (GRCh38): ENSG00000131187
EnsemblGeneIds (GRCh37): ENSG00000131187
OMIM: 610619, Gene2Phenotype
F12 is in 6 panels

4 reviews

Kimberly Gilmour (Great Ormond Street Hopsital)

Green List (high evidence)

agree with green gene
Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94

Tracy Briggs (Manchester Genomic Medicine Centre)

Green List (high evidence)

YES- this is covered on our targeted exome
Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94

Sophie Hambleton (Newcastle University)

Green List (high evidence)

NB allelic AR disorder of factor XII deficiency produces Hageman trait
Created: 29 Jun 2018, 1:53 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
hereditary angioedema

Publications

Mode of pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments

Louise Daugherty (Genomics England Curator)

Green List (high evidence)

Gene rating submitted by Kimberly Gilmour and Austen Worth on behalf of London North GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email 6th September the Specialist Test Group all agreed there is enough evidence to rate this gene Green.
Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
Gene rating submitted by Tracy Briggs, David Gokhale and Abigal Rousseau on behalf of North West GLH for the GMS Immunology specialist test group. As discussed with the GMS Immunology Specialist Test Group during webex call 28th March 2019 and confirmed in follow up email on 20th June the Specialist Test Group all agreed there is enough evidence to rate this gene Green.
Created: 17 Sep 2019, 3:18 p.m. | Last Modified: 17 Sep 2019, 3:18 p.m.
Panel Version: 1.94
The missense variants NG_007568.1(NM_000505.3):c.983C>A;p.Thr328Lys and NG_007568.1(NM_000505.3):c.983C>G;p.Thr328Arg affect the threonine residue at position 328 of the protein.1, 2 The p.Thr328Lys variant accounts for the large majority of variant-positive cases reported to date. p.Thr328Lys has been described in patients/families from various ethnic backgrounds. In addition to the two missense variants, one deletion and one duplication have been reported in single families. The NG_007568.1(NM_000505.3):c.971_1018+24del;p.Lys324_Ala340delinsThr variant is a deletion of 72 base pairs (bp). As with the missense variants, the duplication and the deletion affect the proline-rich region
Created: 3 Jul 2018, 11:29 a.m.
Comment on list classification: Changed Amber to Green from external expert review and further publications to support gene-disease association. To date, four disease-causing variants in F12 have been reported .
Created: 3 Jul 2018, 11:26 a.m.
Contrary to HAE types 1 and 2, HAE type 3 occurs mainly in women and attacks are often associated with increased estrogen levels (pregnancy, oral contraception, hormonal replacement therapy).
Created: 3 Jul 2018, 11:24 a.m.
Comment on mode of pathogenicity: added Mode of Pathogenicity as suggested by external expert review
Created: 3 Jul 2018, 10:47 a.m.
Comment on publications: added publications suggested from external expert review to support upgrading of the gene to Green
Created: 3 Jul 2018, 10:46 a.m.
This gene was absent from the original PanelApp PID panel dataset (review April 2018). However it was listed in external expert immunodeficiency diagnostic gene list(s) GOSH or GRID. In this combined PID panel, this gene has been rated as AMBER and needs further curational review to assess pertinence prior to v1.
Created: 20 Apr 2018, 12:25 p.m.
Original metadata supplied by GRID. GRID Gene Symbol HGNC PanelApp check: F12, GRID_Gene_Symbol: F12, GRID_Transcript_ENS_Community submitted: ENST00000253496, GRID_Transcript_RefSeq: NM_000505.3, GRID_Transcript_ENS_used_on_Production: ENST00000253496
Created: 17 Apr 2018, 12:12 p.m.

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • London North GLH
  • NHS GMS
  • GRID V2.0
  • North West GLH
  • Victorian Clinical Genetics Services
  • Expert Review Green
  • NHS GMS
  • North West GLH
  • London North GLH
  • Expert Review Green
  • Victorian Clinical Genetics Services
  • GRID V2.0
Phenotypes
  • Angioedema, hereditary, 3, OMIM:610618
OMIM
610619
Clinvar variants
Variants in F12
Penetrance
None
Publications
Mode of Pathogenicity
Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments
Panels with this gene

History Filter Activity

21 Mar 2022, Gel status: 3

Set Phenotypes

Arina Puzriakova (Genomics England Curator)

Phenotypes for gene: F12 were changed from hereditary angioedema; Angioedema, Hereditary, Type III to Angioedema, hereditary, 3, OMIM:610618

1 Apr 2020, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set mode of pathogenicity

Ellen McDonagh (Genomics England Curator)

gene: F12 was added gene: F12 was added to Viral susceptibility. Sources: Expert Review Green,Victorian Clinical Genetics Services,North West GLH,GRID V2.0,NHS GMS,London North GLH Mode of inheritance for gene: F12 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: F12 were set to 17186468; 16638441; 19178938 Phenotypes for gene: F12 were set to hereditary angioedema; Angioedema, Hereditary, Type III Mode of pathogenicity for gene: F12 was set to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments